Altamira Medica Receives China Approval for Bentrio Nasal Spray

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Dec 19 2025

0mins

Altamira Therapeutics announced that its associate company Altamira Medica has obtained marketing approval from the National Medical Products Administration of China for its Bentrio nasal spray in allergic rhinitis. The clearance will allow Nuance Pharma, Medica's licensee and distribution partner, to start marketing and distributing Bentrio in Mainland China.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.